Amy Morgan
Head of Emerging Markets, London
Amy has over 20 years’ experience in custom research in emerging markets having coordinated and completed over 300 assignments spanning a spectrum of therapeutic indications - from vaccines to oncology to orphan therapeutics - in more than 40 markets worldwide. Over this time, she has built up a broad network of in-country stakeholders and contacts enabling her to leverage deep knowledge and understanding into local market situations and deliver bespoke, client-orientated insights and recommendations. She has expertise in landscape assessments, funding mechanisms, identifying market access challenges and potential reimbursement barriers, payer and KOL engagement, value proposition testing and pricing strategy.
As a founding partner at Parioforma Limited, Amy gained a wealth of consulting experience in the healthcare and life science industry. She is skilled at designing research programs that deliver focused results to steer client strategic direction and decision-making. She has also authored many technology and market specific reports. Prior to founding Parioforma, she was a senior analyst in the Pharmaceuticals and Chemicals practice at InterMatrix.
Amy holds an MA (Hons) degree in Chemistry from Oxford University. In her spare time, Amy enjoys the theater and arts, oil painting, travel and keeping fit. It is her goal to fulfill a lifelong ambition of learning to fly!